SEC Comment Letter for PharmaCyte Biotech, Inc. (PMCB) (CIK 0001157075) (PMCB) — Mar 30, 2010

PharmaCyte Biotech, Inc. (PMCB) (CIK 0001157075)
Date: March 30, 2010 · CIK: 0001157075 · Accession: 0000000000-10-017416

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-68008

Date

March 30, 2010

Author

Not clearly detected

Form

UPLOAD

Company

PharmaCyte Biotech, Inc. (PMCB) (CIK 0001157075)

Letter

Via Facsimile and U.S. Mail Mail Stop 4720 March 30, 2010 Martin Schmieg Chief Executive Officer Nuvilex, Inc. 1971 Old Cuthbert Road Cherry Hill, NJ 08034

Re: Nuvilex, Inc. Item 4.01 Form 8-K Filed March 9, 2010 File No. 333-68008

Dear Mr. Schmieg:

We have completed our review of your Form 8-K and have no further comments at this time.

S i n c e r e l y , J i m P e k l e n k S t a f f A c c o u n t a n t

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 4720                                                                                                   March 30, 2010   Martin Schmieg Chief Executive Officer
Nuvilex, Inc.
1971 Old Cuthbert Road
Cherry Hill, NJ  08034

Re: Nuvilex, Inc.
 Item 4.01 Form 8-K
 Filed March 9, 2010
 File No. 333-68008

Dear Mr. Schmieg:

 We have completed our review of your Form 8-K and have no further
comments at this time.

        S i n c e r e l y ,
           J i m  P e k l e n k          S t a f f  A c c o u n t a n t

SecProbe.io